Sacubitril 24mg + Valsartan 26mg
Sacubitril inhibits neprilysin, increasing levels of beneficial natriuretic peptides that reduce fluid retention, dilate vessels, and reverse cardiac remodelling. Valsartan blocks angiotensin II to lower blood pressure and reduce cardiac load. This ARNI combination is the most advanced heart failure pharmacotherapy.
Heart failure with reduced ejection fraction (HFrEF), as a replacement for ACE inhibitors or ARBs.
Take as prescribed by your doctor or healthcare professional. Do not self-medicate.
VALSCUB 50 is a starting dose of the most advanced heart failure therapy available — proven to reduce mortality beyond standard ACE inhibitor therapy for patients with reduced ejection fraction.
Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.